✦ LIBER ✦

PPARα and PPARδ nuclear receptor regulation of body weight and hepatic steatosis

✍ Scribed by Wojciech Garbacz; Larry Higgins; Colin Palmer

Book ID: 113934066
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 94 KB
Volume: 290
Category: Article
ISSN: 0300-483X
DOI: 10.1016/j.tox.2011.09.060

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Removal notice to “PPARα and PPARδ nucle

Removal notice to “PPARα and PPARδ nuclear receptor regulation of body weight and hepatic steatosis” [Toxicology 290 (2011) 135]

✍ Garbacz, Wojciech; Higgins, Larry; Palmer, Colin 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Oleylethanolamide regulates feeding and

Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α

✍ Fu, Jin; Gaetani, Silvana; Oveisi, Fariba; Lo Verme, Jesse; Serrano, Antonia; Ro 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 341 KB

Expression of adiponectin receptors in h

Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARα, PPARγ, and LXR

✍ G Chinetti; C Zawadski; J.C Fruchart; B Staels 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 279 KB

Hepatic nuclear receptor PPARα in the ko

Hepatic nuclear receptor PPARα in the koala (Phascolarctos cinereus): Cloning and molecular characterisation

✍ Suong Ngoc Thi Ngo; Ross Allan McKinnon; Ieva Stupans 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 842 KB

Regulation of miR-200c by nuclear recept

Regulation of miR-200c by nuclear receptors PPARα, LRH-1 and SHP

✍ Yuxia Zhang; Zhihong Yang; Richard Whitby; Li Wang 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 615 KB

Regulation of Wnt/β-catenin pathway by c

Regulation of Wnt/β-catenin pathway by cPLA2α and PPARδ

✍ Chang Han; Kyu Lim; Lihong Xu; Guiying Li; Tong Wu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB

## Abstract Cytosolic phospholipase A~2~α (cPLA~2~α) is a rate‐limiting key enzyme that releases arachidonic acid (AA) from membrane phospholipid for the production of biologically active lipid mediators including prostaglandins, leukotrienes and platelet‐activating factor. cPLA~2~α is translocated